Every Day Counts — a lifestyle program for women with metastatic breast cancer
Every Day Counts: A lifestyle program for women metastatic breast cancer
This program helps women living with metastatic breast cancer use exercise, strength training, and nutrition support to improve strength, body composition, blood markers, and daily quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11283938 on NIH RePORTER |
What this research studies
You would join a structured lifestyle program that includes physical activity, strength training, and nutrition guidance tailored for women with metastatic breast cancer. The study team will measure your body fat and muscle mass, physical strength and activity levels, blood biomarkers, and quality of life over time. Some participants will begin the program right away while others will start later so researchers can compare results between groups. The investigators previously ran a pilot that showed participants could take part, stick with the program, and see improvements in symptoms, strength, and some biomarkers.
Who could benefit from this research
Good fit: Ideal candidates are women living with metastatic breast cancer who are medically cleared to participate in an exercise and lifestyle program and can commit to scheduled visits and activities.
Not a fit: Patients who are too medically fragile, have active contraindications to exercise or the intervention components, or cannot attend program activities are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the program could improve physical strength, reduce unhealthy body fat, improve biomarkers tied to prognosis, and enhance overall quality of life for women with metastatic breast cancer.
How similar studies have performed: Lifestyle programs have improved symptoms, fitness, and biomarkers in early-stage breast cancer survivors, and the study team's pilot data in metastatic patients showed promising and clinically meaningful improvements.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Stolley, Melinda R — Medical College of Wisconsin
- Study coordinator: Stolley, Melinda R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.